Polyethylene glycol-grafted poly- l-lysine as polymeric gene carrier
A new series of gene carriers, polyethylene glycol (PEG)-grafted poly- l-lysine (PLL, mol. wt.=25 000) with three different PEG-grafted ratios (5, 10 and 25 mole%, which means 5, 10 and 25% of ϵ-amino group of PLL was modified by PEG), was synthesized. These new gene carriers, named comb-shaped PEG-...
Saved in:
Published in | Journal of controlled release Vol. 54; no. 1; pp. 39 - 48 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
01.06.1998
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new series of gene carriers, polyethylene glycol (PEG)-grafted poly-
l-lysine (PLL, mol. wt.=25 000) with three different PEG-grafted ratios (5, 10 and 25 mole%, which means 5, 10 and 25% of ϵ-amino group of PLL was modified by PEG), was synthesized. These new gene carriers, named comb-shaped PEG-
g-PLL copolymer, showed a 5- to 30-fold increase in transfection efficiency compared to PLL alone on a human carcinoma cell line. It is likely that Hep G2 cells were transfected by plasmid DNA/PEG-
g-PLL complexes through an endocytosis mechanism due to the fact that chloroquine increased transfection efficiency. Although Lipofectin™, a cationic lipid formulation, showed slightly higher transfection efficiency than PEG-
g-PLL in Hep G2 cells, our designed PEG-
g-PLL demonstrated lower cytotoxicity, early gene expression and maintenance of gene expression for up to 96 h. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0168-3659 1873-4995 |
DOI: | 10.1016/S0168-3659(97)00174-0 |